Initiation of oral anticoagulant therapy in orthopedic and surgical patients: An algorithm compared with routine dosing

European Journal of Clinical Pharmacology

Volumn 58, Issue 3, 2002, Pages 203-208

  Van Den Bemt, P ^a   Beinema, M ^b   Van Roon, E ^c   Sijtsma, J ^d   Baars, W ^e   Mencke, H ^d   Brouwers, J ^e  

^a GGZ Midden Brabant   (Netherlands)

^b DEVENTER HOSPITAL   (Netherlands)

^c MEDICAL CENTER LEEUWARDEN   (Netherlands)

^d Tjongerschans Hospital   (Netherlands)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Acenocoumarol; Algorithm; Hospital; Initiation; Oral anticoagulant; Routine dosing

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ALGORITHM; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG SAFETY; FEMALE; GENERAL SURGERY; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPOTHESIS; INTERNATIONAL STANDARD UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SENESCENCE; SINGLE BLIND PROCEDURE; THROMBOEMBOLISM; WARD; COMORBIDITY; INTERNATIONAL NORMALIZED RATIO; MIDDLE AGED; NETHERLANDS; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; VEIN THROMBOSIS;

ACENOCOUMAROL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTICOAGULANTS; COMORBIDITY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGE; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOSIS; HUMANS; MIDDLE AGED;

EID: 0035984794     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-002-0477-y     Document Type: Article

References (19)

1. Guidelines on oral anticoagulation: Third edition
2. Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy
3. Stabilisation of oral anticoagulant therapy in hospitalised patients and characteristics associated with lack of stabilisation
4. Evaluation of three dosage-prediction methods for initial in-hospital stabilisation of warfarin therapy
5. Prevention of venous thromboembolic disease following primary total knee arthroplasty
6. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
7. The possession of the CYP2C9*3 allele is associated with low dose requirement of acenocoumarol
8. Flexible induction dose regimen for warfarin and prediction of maintenance dose
9. Initiation of warfarin therapy: Comparison of physician dosing with computer-assisted dosing
10. Evaluation of a decision support system for initiation and control of oral anticoagulation in a randomised trial
11. Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease
12. Initialization of warfarin dosages using computer modeling
13. Multicentre randomised study of computerised anticoagulant dosage
14. Standardised initial warfarin treatment: Evaluation of initial treatment response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response
15. A computer generated induction system for hospitalized patients starting on oral anticoagulant therapy
16. The association of age with dosage requirement for warfarin
17. Evaluation of warfarin initiation regimens in elderly inpatients
18. Hemorrhagic complications of anticoagulant treatment